CCL
44
-3
DVA
75
-2
PNR
69
-2
BBY
50
-2
MO
39
-2
AKAM
56
-2
ECL
70
-4
IVZ
52
-4
EMC
59
3
SCHW
36
-4
PFE
21
-2
NUE
54
3
BAC
32
-4
GME
61
-4
GS
50
-2
WBA
45
-3
AEP
51
-2
CI
58
2
KLAC
57
-2
CB
61
3
CCL
44
-3
DVA
75
-2
PNR
69
-2
BBY
50
-2
MO
39
-2
AKAM
56
-2
ECL
70
-4
IVZ
52
-4
EMC
59
3
SCHW
36
-4
PFE
21
-2
NUE
54
3
BAC
32
-4
GME
61
-4
GS
50
-2
WBA
45
-3
AEP
51
-2
CI
58
2
KLAC
57
-2
CB
61
3
Financhill
Back

EyePoint Pharmaceuticals Vs. Apellis Pharmaceuticals Industry Stock Comparison

Sell
40

EYPT
EyePoint Pharmaceuticals

Last Price:
8.23
Seasonality Move:
-9.25%
Sell
19

APLS
Apellis Pharmaceuticals

Last Price:
27.84
Seasonality Move:
29.59%
Sell
40
EyePoint Pharmaceuticals (EYPT) is a Sell

Is EyePoint Pharmaceuticals a Buy, Sell or Hold?

  • The current EyePoint Pharmaceuticals [EYPT] share price is $8.01. The Score for EYPT is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • EYPT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
19
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $27.72. The Score for APLS is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

EYPT Stock Price Chart

What is EyePoint Pharmaceuticals's stock price today?

  • The EyePoint Pharmaceuticals share price today is $8.01
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EYPT is experiencing buying pressure, which is a positive indicator for future bullish movement.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $27.72
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing slight selling pressure.

EYPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.16 Sell
Relative Strength Index (14 RSI): 42.06 Sell
Chaikin Money Flow: 232993 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (8.06 - 8.9) Sell
Bollinger Bands (100): (8.03 - 10.53) Sell

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.52 Sell
Relative Strength Index (14 RSI): 24.36 Sell
Chaikin Money Flow: -686449 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (31.66 - 39.6) Sell
Bollinger Bands (100): (35.11 - 41.59) Sell

EYPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 8.22 Sell
20-day SMA: 8.42 Sell
50-day SMA: 8.66 Sell
200-day SMA: 15.98 Sell
8-day EMA: 8.2 Sell
20-day EMA: 8.4 Sell
50-day EMA: 8.83 Sell
200-day EMA: 12.03 Sell

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 30.3 Sell
20-day SMA: 34.83 Sell
50-day SMA: 36.62 Sell
200-day SMA: 48.86 Sell
8-day EMA: 30.46 Sell
20-day EMA: 33.43 Sell
50-day EMA: 36.2 Sell
200-day EMA: 44.63 Sell

EyePoint Pharmaceuticals Earnings Growth & EYPT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.42 per share, and a decrease next year of $0.94 per share.

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.23 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.30 per share, and an increase next year of $1.38 per share.

EyePoint Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):